Stephen M. Stahl, M.D., Ph.D.

Brainstorms

Neurotransmission of Cognition, Part 3. Mechanism of Action of Selective NRIs: Both Dopamine and Norepinephrine Increase in Prefrontal Cortex

March 15, 2003

Article

Describing an Atypical Antipsychotic: Receptor Binding and Its Role in Pathophysiology

March 1, 2003

Brainstorms

Neurotransmission of Cognition, Part 2 Selective NRIs Are Smart Drugs: Exploiting Regionally Selective Actions on Both Dopamine and Norepinephrine to Enhance Cognition

February 15, 2003

Brainstorms

Neurotransmission of Cognition, Part 1: Dopamine Is a Hitchhiker in Frontal Cortex: Norepinephrine Transporters Regulate Dopamine

January 15, 2003

Letter to the Editor

Reply to Letter to the Editor "Combination Therapy: Is Clinical Practice Leading the Way?"

January 15, 2003

Brainstorms

"The Metabolic Syndrome": Psychopharmacologists Should Weigh the Evidence for Weighing the Patient

December 1, 2002

Academic Highlights

Using Atypical Antipsychotics in Primary Care

December 1, 2002

Brainstorms

Can Psychopharmacologic Treatments That Relieve Symptoms Also Prevent Disease Progression?

November 1, 2002

Brainstorms

Independent Actions on Fear Circuits May Lead to Therapeutic Synergy for Anxiety When Combining Serotonergic and GABAergic Agents

October 1, 2002

Brainstorms

Don't Ask, Don't Tell, but Benzodiazepines Are Still the Leading Treatments for Anxiety Disorder

September 23, 2002

Brainstorms

Mirror, Mirror on the Wall, Which Enantiomer Is Fairest of Them All?

August 15, 2002

Brainstorms

Psychopharmacology of Wakefulness: Pathways and Neurotransmitters

July 16, 2002